✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Sulopenem is an investigational drug.
There have been 6 clinical trials for Sulopenem. The most recent clinical trial was a Phase 3 trial, which was initiated on September 18th 2018.
The most common disease conditions in clinical trials are Infection, Communicable Diseases, and Urinary Tract Infections. The leading clinical trial sponsors are Iterum Therapeutics, International Limited, Iterum Therapeutics, US Limited, and Pfizer.
There are two hundred and thirty US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for Sulopenem
|Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents||Iterum Therapeutics, International Limited||Phase 1|
|Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults||Iterum Therapeutics, International Limited||Phase 3|
|Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults||Iterum Therapeutics, US Limited||Phase 3|
Top disease conditions for Sulopenem
Top clinical trial sponsors for Sulopenem
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Sulopenem||See Plans and Pricing||Methods of treating inflammation associated airway diseases and viral infections||WASHINGTON STATE UNIVERSITY (Pullman, WA) THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, TX)||See Plans and Pricing|
|Sulopenem||See Plans and Pricing||Use of gelsolin to treat infections||The Brigham and Women's Hospital, Inc. (Boston, MA)||See Plans and Pricing|
|Sulopenem||See Plans and Pricing||Compositions and methods for delivering an agent to a wound||UNIVERSITY OF MEMPHIS RESEARCH FOUNDATION (Memphis, TN)||See Plans and Pricing|
|Sulopenem||See Plans and Pricing||Oral appliance for delivering a medicament||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Sulopenem||Australia||AU2005244865||2024-05-12||See Plans and Pricing|
|Sulopenem||Canada||CA2607686||2024-05-12||See Plans and Pricing|
|Sulopenem||Canada||CA2860173||2024-05-12||See Plans and Pricing|
|Sulopenem||China||CN1980694||2024-05-12||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|